Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
Circulation · 25.07.2023 · 148 (4) · 354-372
DOI: 10.1161/circulationaha.123.064346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation, erschienen am 25.07.2023. Verfasst von Milton Packer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Baylor Heart and Vascular Institute, Dallas, TX (M.P.). Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Heart Failure. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
SGLT2 (sodium-glucose cotransporter 2) inhibitors interfere with the reabsorption of glucose and sodium in the early proximal renal tubule, but the magnitude and duration of any ensuing natriuretic or diuretic effect are the result of an interplay between the degree of upregulation of SGLT2 and sodium-hydrogen exchanger 3, the extent to which downstream compensatory tubular mechanisms are activated, and (potentially) the volume set point in individual patients. A comprehensive review and synthesis of available studies reveals several renal response patterns with substantial variation across studies and clinical settings. However, the common observation is an absence of a large acute or chronic diuresis or natriuresis with these agents, either when given alone or combined with other diuretics. This limited response results from the fact that renal compensation to these drugs is rapid and nearly complete within a few days or weeks, preventing progressive volume losses. Nevertheless, the finding that fractional excretion of glucose and lithium (the latter being a marker of proximal sodium reabsorption) persists during long-term treatment with SGLT2 inhibitors indicates that pharmacological tolerance to the effects of these drugs at the level of the proximal tubule does not meaningfully occur. This persistent proximal tubular effect of SGLT2 inhibitors can be hypothesized to produce a durable improvement in the internal set point for volume homeostasis, which may become clinically important during times of fluid expansion. However, it is difficult to know whether a treatment-related change in the volume set point actually occurs or contributes to the effect of these drugs to reduce the risk of major heart failure events. SGLT2 inhibitors exert cardioprotective effects by a direct effect on cardiomyocytes that is independent of the presence of or binding to SGLT2 or the actions of these drugs on the proximal renal tubule. Nevertheless, changes in the volume set point mediated by SGLT2 inhibitors might potentially act cooperatively with the direct favorable molecular and cellular effects of these drugs on cardiomyocytes to mediate their benefits on the development and clinical course of heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Baylor Heart and Vascular Institute, Dallas, TX (M.P.).
- Imperial College London, United Kingdom (M.P.).
- Division of Nephrology and Hypertension, Kidney, and Vascular Research Center, Georgetown University, Washington, DC (C.S.W.).
- Section of Cardiovascular Medicine, Yale University, New Haven, CT (J.M.T.).
ORCID-Profile: Milton Packer, Christopher S Wilcox, Jeffrey M Testani
Förderung
- NCATS NIH HHS
Zitieren
APA
Packer, M., Wilcox, C. S., & Testani, J. M. (2023). Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes. Circulation, 148(4), 354-372. https://doi.org/10.1161/circulationaha.123.064346
Vancouver
Packer M, Wilcox CS, Testani JM. Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes. Circulation. 2023;148(4):354-372. doi:10.1161/circulationaha.123.064346
BibTeX
@article{Packer2023,
author = {Packer, Milton and Wilcox, Christopher S and Testani, Jeffrey M},
title = {Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes},
journal = {Circulation},
year = {2023},
volume = {148},
number = {4},
pages = {354--372},
doi = {10.1161/circulationaha.123.064346}
}
EUVIMED